Gene · 5270
Papers2,089
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,089
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Study of the Extracellular Matrix in Chronic Inflammation: A Way to Prevent Cancer Initiation? | Cancers (Basel) | 2022 | 36497384 | PubTator, text mining | PubMed |
| Single-cell profiling of healthy human kidney reveals features of sex-based transcriptional programs and tissue-specific immunity. | Nat Commun | 2022 | 36496458 | PubTator, text mining | PubMed |
| The role of preoperative inflammatory markers in patients with central nervous system tumors, focus on glioma. | Front Oncol | 2022 | 36483052 | PubTator, text mining | PubMed |
| Amplification Free Detection of SARS-CoV-2 Using Multi-Valent Binding. | ACS Sens | 2022 | 36482673 | PubTator, text mining | PubMed |
| An IGF1-expressing endometrial stromal cell population is associated with human decidualization. | BMC Biol | 2022 | 36482461 | PubTator, text mining | PubMed |
| The Spectrum of Histomorphological Changes and Pathological Tumor Response following Preoperative Oral Metronomic Chemotherapy in Oral Squamous Cell Carcinoma. | South Asian J Cancer | 2022 | 36466986 | PubTator, text mining | PubMed |
| Development and external validation of a novel nomogram model for predicting postoperative recurrence-free survival in non-muscle-invasive bladder cancer. | Front Immunol | 2022 | 36458001 | PubTator, text mining | PubMed |
| The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy. | PLoS One | 2022 | 36454803 | PubTator, text mining | PubMed |
| Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer. | Nature | 2022 | 36450981 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing identifies a paracrine interaction that may drive oncogenic notch signaling in human adenoid cystic carcinoma. | Cell Rep | 2022 | 36450256 | PubTator, text mining | PubMed |
| Long-range allostery mediates the regulation of plasminogen activator inhibitor-1 by cell adhesion factor vitronectin. | J Biol Chem | 2022 | 36444882 | PubTator, text mining | PubMed |
| Endocytosis of Peptidase Inhibitor SerpinE2 promotes Myocardial Fibrosis through activating ERK1/2 and β-catenin Signaling Pathways. | Int J Biol Sci | 2022 | 36439874 | PubTator, text mining | PubMed |
| Spontaneous Transformation of a p53 and Rb-Defective Human Fallopian Tube Epithelial Cell Line after Long Passage with Features of High-Grade Serous Carcinoma. | Int J Mol Sci | 2022 | 36430324 | PubTator, text mining | PubMed |
| Identification of Factors Driving Doxorubicin-Resistant Ewing Tumor Cells to Survival. | Cancers (Basel) | 2022 | 36428591 | PubTator, text mining | PubMed |
| Using Cumulus Cell Biopsy as a Non-Invasive Tool to Access the Quality of Bovine Oocytes: How Informative Are They? | Animals (Basel) | 2022 | 36428341 | PubTator, text mining | PubMed |
| Genome-Wide RNA Sequencing of Human Trabecular Meshwork Cells Treated with TGF-β1: Relevance to Pseudoexfoliation Glaucoma. | Biomolecules | 2022 | 36421707 | PubTator, text mining | PubMed |
| Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation. | J Med Life | 2022 | 36415513 | PubTator, text mining | PubMed |
| [Multimodal treatment of high-risk and locally advanced prostate cancer]. | Urologie | 2022 | 36413269 | PubTator, text mining | PubMed |
| Profiling mRNA, miRNA and lncRNA expression changes in endothelial cells in response to increasing doses of ionizing radiation. | Sci Rep | 2022 | 36402833 | PubTator, text mining | PubMed |
| Proteome-wide Mendelian randomization in global biobank meta-analysis reveals multi-ancestry drug targets for common diseases. | Cell Genom | 2022 | 36388766 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5270/papers?page=23